The history of Sildenafil presents a intricate picture for shareholders. While the initial release generated significant profits, the expiration of its exclusive rights opened the door to cheaper alternatives, https://indexedbookmarks.com/story21547132/the-copyright-and-the-pharmaceutical-industry-a-volatile-opportunity